Life Sciences
United Kingdom Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
The UK is lagging behind many other countries that have built proton beam therapies in their hospitals over the last few years. The UK has only one proton beam therapy facility, a small unit at the Clatterbridge Cancer Centre, which can deliver treatment to patients with eye cancers such as choroidal melanoma.
Switzerland Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
Being a conventional proton therapy center of Europe, Switzerland remains flooded with the demand for proton therapy by patients converging from all over the globe. Currently, there are only a few proton therapy centers available in Switzerland that can treat a limited number of patients each year due to the gap in demand and supply.
Czech Republic Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
Proton therapy is a relatively new, albeit expensive, strategy for treating certain types of cancers (e.g. breast, prostate, ocular), currently available inexpensively in only a handful of countries around the world. In Czech Republic, currently only 1 proton therapy center is operational. The Prague Proton Therapy Center opened its doors in 2012.
Germany Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
Germany is the largest market for proton therapy in the European region. Currently, six proton therapy centers are operational in Germany. Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge potential market.
France Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
With an increasing incidence of cancer, there is a definite need for novel, cutting edge, treatment methods, such as, Proton Therapy. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers. In France, currently only 2 proton therapy centers are operational.
Italy Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
The proton therapy market in Italy is anticipated to grow at a CAGR of around 25% during the period 2017 – 2022. In Italy, there are 3 proton beam therapy centers, which considerably boosts their capacity to treat a greater number of patients. The treatment of the first local patients with proton beams was administered in 2002 at Catania’s INFN-LNS.
Poland Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
Proton Therapy is one of the most technologically advanced treatments for cancer. With an increasing incidence of cancer, there is a definite need for novel, cutting edge, treatment methods, such as, Proton Therapy. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers.
Russia Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
In Russia, 3 proton therapy centers are operational while another 3 centers are in under construction/planned phase.The continuing exploration of the benefits of proton therapy is inspiring a growing and massive construction of new proton centers across Russia.
Sweden Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
Proton Therapy is one of the most technologically advanced treatments for cancer. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers. There are only two operational proton therapy center in Sweden.
Asia Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
Asia proton therapy market is anticipated to almost three-fold during the period 2016 – 2022. The number of proton therapy centers is continuously increasing in Asia. Still, it is believed that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi-Billion-dollar potential market.
Japan Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
Japan proton therapy market is anticipated to grow at a CAGR of around 18% during the period 2017 – 2022. The number of proton therapy centers is continuously increasing in Japan. Mitsubishi is the leading player in proton therapy market in Japan.
China Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
Cancer incidence and mortality have been increasing in China, making cancer the leading cause of death since 2010 and a major public health problem in the country. With an increasing incidence of cancer, there is a definite need for novel, cutting edge, treatment methods, such as, Proton Therapy.
South Korea Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
The number of patients treated with Proton Therapy in South Korea is very low whereas; the potential candidates for proton therapy are huge. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers.
United States Proton Therapy Market (Actual & Potential), Patients Treated, List Of Proton Therapy Centers And Forecast To 2022
IBA dominates the proton therapy market. However, other players like Varian, Mevion, Hitachi etc. have also started to make their presence felt in the market. The increased demand for proton therapy has motivated many prominent cancer centers in the world to provide proton therapy treatment.
Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis And Forecast To 2022
Geographically, North America is the largest market for influenza vaccines capturing nearly 50% market share in 2016. Asia is the second largest market for influenza vaccines. Europe is the third largest market for influenza vaccines, followed by Latin America with around XX% share in 2016. Australasia accounted for least share of the influenza vaccines market in 2016.